ClearBridge Investments - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 1 filers reported holding CLOVIS ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ClearBridge Investments ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2017$1,719,000
-25.6%
27,000
-48.1%
0.00%
-33.3%
Q4 2016$2,310,000
+23.2%
52,0000.0%0.00%
+50.0%
Q3 2016$1,875,000
+16945.5%
52,000
+21387.6%
0.00%
Q3 2014$11,000
+10.0%
2420.0%0.00%
Q2 2014$10,000
-82.8%
242
-70.9%
0.00%
Q1 2014$58,000
+132.0%
832
+102.9%
0.00%
Q4 2013$25,0000.0%4100.0%0.00%
Q3 2013$25,0004100.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,997,826$10,834,0000.69%
Ikarian Capital, LLC 1,112,669$3,016,0000.45%
Versant Venture Management, LLC 101,855$276,0000.15%
Virtus ETF Advisers LLC 60,836$165,0000.06%
EMFO, LLC 21,500$58,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
PINNACLE ASSOCIATES LTD 706,336$1,914,0000.03%
XTX Topco Ltd 20,920$57,0000.03%
State of Wyoming 25,419$69,0000.03%
View complete list of CLOVIS ONCOLOGY INC shareholders